NOTICE of Intent to SOLE SOURCE - Agilent Technologies, Inc.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), under the Department of Health and Human Services, has issued a Notice of Intent to Sole Source the purchase of an Agilent Cary 630 FTIR spectrometer with MicroLab Expert software from Agilent Technologies, Inc. This equipment is required for advanced infrared spectral analysis of occupational agents and biological samples. Responses from interested parties are due by June 30, 2026.
Scope of Work
The requirement is for the acquisition of an Agilent Cary 630 FTIR spectrometer, including its associated MicroLab Expert software. This system will be utilized for sophisticated infrared spectral analysis, specifically targeting occupational agents and various biological samples within the CDC's research and analytical operations.
Contract & Timeline
- Type: Special Notice (Notice of Intent to Sole Source)
- Set-Aside: None specified
- Response Due: June 30, 2026, 12:00 PM ET
- Published: June 15, 2026, 12:38 PM ET
- Department/Agency: Health And Human Services / CENTERS FOR DISEASE CONTROL AND PREVENTION
- Office: CDC OFFICE OF ACQUISITION SERVICES
- Place of Performance: Atlanta, GA 30341, United States
Additional Notes
This notice serves as an intent to award a sole source contract to Agilent Technologies, Inc. The CDC believes that Agilent Technologies, Inc. is the only responsible source capable of providing the required spectrometer and software. Any other interested party who believes they can meet this requirement must submit a capabilities statement demonstrating their ability to provide the specified equipment by the response date. For inquiries, contact Marcus Lindsey at yzg2@cdc.gov or 770-488-5242.